|
|
Identification |
|
Name |
|
R-Elvitegravir |
|
Synonyms |
|
6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1R)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid |
|
|
Molecular Structure |
|
![CAS # 1177256-05-1, R-Elvitegravir, 6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1R)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid](/structures/1177256-05-1.gif) |
|
|
Molecular Formula |
|
C23H23ClFNO5 |
|
Molecular Weight |
|
447.88 |
|
CAS Registry Number |
|
1177256-05-1 |
| |
|
Properties |
|
|
Solubility |
|
Insoluble (1.2E-4 g/L) (25 ºC), Calc.* |
|
Density |
|
1.357±0.06 g/cm3 (20 ºC 760 Torr), Calc.* |
|
Melting point |
|
150-151 ºC** |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
|
|
**
|
Sato, Motohide; Journal of Medicinal Chemistry 2009, V52(15), P4869-4882.
|
|
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
